Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial

Progress in Cardiovascular Diseases

Volumn 38, Issue 5, 1996, Pages 359-370

  Reiffel, J A ^a   Reiter, M J ^a   Freedman, R A ^a   Mann, D ^a   Huang, S K S ^a   Hahn, E ^a   Hartz, V ^a   Mason, J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0029871407     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(96)80029-6     Document Type: Article

References (45)

1. for the ESVEM Investigators Mason JW A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic drug efficacy for ventricular tachyarrhythmias N Engl J Med 329 1993 445 451
2. Mitchell LB Duff HJ Manyori DE A randomized clinical trial of noninvasive and invasive approaches to drug therapy of ventricular tachycardia N Engl J Med 317 1987 1681 1687
3. Ruskin JR DiMarco JP Garan H Electrophysiologic observations and selection of long term antiarrhythmic therapy N Engl J Med 303 1980 607 613
4. Wilber DJ Garan H Finkelstein D Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long term outcome N Engl J Med 318 1988 19 24
5. Grayboys TB Lown B Podrid PJ Long term survival of patients with ventricular arrhythmia treated with antiarrhythmic drugs Am J Cardiol 50 1982 437 443
6. Vlay SL Kallman LH Reid PR Prognostic assessment of survivors of ventricular tachycardia and ventricular fibrillation with ambulatory monitoring Am J Cardiol 54 1984 87 90
7. Platia EV Reid PR Comparison of programmed electrical stimulation and ambulatory (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation J Am Coll Cardiol 4 1984 493 500
8. Ezri MD Huang SK Denes P The role of Holter monitoring in patients with recurrent sustained ventricular tachycardia: An electrophysiologic correlation Am Heart J 108 1986 1229 1236
9. Skale BT Miles WM Heger JJ Survivors of cardiac arrest: Prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring Am J Cardiol 57 1986 113 119
10. Waller TJ Kay MR Spielman SR Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmia J Am Coll Cardiol 10 1987 83 89
11. Hoffman A Schutz E White E Suppression of high grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease Am Heart J 107 1989 1103 1108
12. Hohnloser S Raeder EA Podrid PJ Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachycardia Am Heart J 114 1987 1 14
13. Kim SG Seiden SW Matos JA Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia J Am Coll Cardiol 6 1985 339 344
14. The ESVEM Investigators The ESVEM Trial: Electrophysiologic study versus electrocardiographic monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias Circulation 79 1989 1354 1360
15. Greenspan AM Determinants of antiarrhythmic drug efficacy for ventricular tachyarrhythmias using ambulatory monitoring and electrophysiological techniques Circulation 87 1993 643 645
16. Ward DE Camm AJ Dangerous ventricular arrhythmias: can we predict drug efficacy? N Engl J Med 329 1993 498 499
17. Mason JW Anderson KP Freedman RA Techniques and criteria in electrophysiologic study of ventricular tachycardia Circulation 75 suppl III 1987 125 130
18. Morganroth J Michelson EL Horowitz LN Limitations of routine long term electrocardiographic monitoring to assess ventricular ectopic frequency Circulation 58 1978 408 414
19. CAPS Investigators The Cardiac Arrhythmia Pilot Study Am J Cardiol 57 1986 91 95
20. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 412
21. Brugada P Abdollah H Heddlle B Results of a ventricular stimulation protocol using a maximum of a 4 premature stimuli in patients with documented or suspected ventricular arrhythmia Am J Cardiol 52 1983 1214 1218
22. Prystowsky EN Miles WM Evans JJ Induction of ventricular tachycardia during programmed electrical stimulation: analysis of pacing methods Circulation 73 suppl II 1986 32 38
23. Josephson ME Horowitz LN Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia Am J Cardiol 43 1979 631 642
24. Livelli FD Bigger JT Jr Reiffel JA Response to programmed ventricular stimulation: sensitivity, specificity, and relationship to heart disease Am J Cardiol 50 1982 452 458
25. Swerdlow CD Winkle RA Mason JW Determinants of survival in patients with ventricular tachycarrhythmias N Engl J Med 305 1983 1436 1442
26. Swerdlow CD Winkle RA Mason JW Prognostic significance of the number of induced ventricular complexes during assessment of therapy for ventricular tachyarrhythmias Circulation 68 1983 400 405
27. Kaplan EL Meier P Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
28. Cox DR Regression models and life-tables J R Stat Soc 34 1972 187 220
29. Goldman L Hashimoto B Cook EF Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale Circulation 64 1981 1227 1234
30. Kalbfleisch JD Prentice RL Comparison of survival curves Kalbfleisch JD Prentice RL The Statistical Analysis of Failure Time Data 1980 Wiley New York, NY 16 91
31. SAS/STAT, release 6.04. Cary, NC, SAS Institute, 1990 (SAS is a registered trademark of the SAS Institute, Inc)
32. Reiter MJ Mann DE Reiffel JA Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM trial Circulation 91 1995 1988 1995
33. Wilber DJ Garan H Finkelstein D Out-of-hospital cardiac arrest: Use of electrophysiologic testing for the prediction of long term outcome N Engl J Med 318 1988 19 24
34. Rae AP Greenspan AM Spielman SR Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies Am J Cardiol 55 1985 1494 1499
35. The CASCADE Investigators Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (The CASCADE Study) Am J Cardiol 72 1993 280 287
36. Waller TJ Kay HR Spielman SR Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmias J Am Coll Cardiol 10 1987 83 89
37. Biblo LA Carlson MD Waldo AL Insights into the electrophysiologic study versus electrocardiographic monitoring trial: Its programmed stimulation protocol may introduce bias when assessing long term antiarrhythmic drug therapy J Am Coll Cardiol 25 1995 1601 1604
38. Winters SL Curwin JH Sotalol and the management of ventricular arrhythmias: Implications of ESVEM PACE 18 1995 377 378
39. Mann DE Luck JL Griffin JC Induction of clinical ventricular tachycardia using programmed stimulation: Value of third and fourth extrastimuli Am J Cardiol 52 1983 501 506
40. Gettes LS ESVEM and the hazards of clinical trials Circulation 91 1995 1908 1910
41. Swerdlow CD Blum J Winkle RA Decreased incidence of antiarrhythmic drug efficacy at electrophysiologic study associated with the use of a third extrastimulus Am Heart J 104 1982 1004 1011
42. Cooper MJ Hunt LJ Palmer KJ Quantitation of day to day variability in mode of induction of ventricular tachyarrhythmias by programmed stimulation J Am Coll Cardiol 11 1988 101 108
43. McPherson CA Rosenfeld LE Batsford WP Day to day reproducibility of responses to right ventricular programmed electrical stimulation: Implications for serial drug testing Am J Cardiol 55 1985 689 695
44. Cooper MJ Hunt LJ Richards DA Effect of repetition of extrastimuli on sensitivity and reproducibility of mode of induction of ventricular tachycardia by programmed stimulation J Am Coll Cardiol 11 1988 1260 1267
45. Rosenbaum ME Wilber DJ Finkelstein D Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy J Am Coll Cardiol 17 1991 133 138